ToolsCalculators
Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis
Identifies hospitalised medical patients who warrant pharmacologic VTE prophylaxis.
Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis
Decompensated cardiac failure
Respiratory failure
Acute stroke (<3 months)
Recent myocardial infarction (<4 weeks)
Acute infection or sepsis
Acute rheumatic disease
Active malignancy
Myeloproliferative syndrome
Nephrotic syndrome
Prior venous thromboembolism
Known thrombophilia
Immobilisation >=3 days
Recent long-distance travel (>6 hours)
Age >60 years
BMI >30 kg/m2
Chronic venous insufficiency
Pregnancy or post-partum
Hormonal therapy (oestrogen/HRT)
Dehydration
Result0 points
Low risk of VTE - routine pharmacologic prophylaxis is generally not required.
- Risk category
- Low risk (<3 points)
When to use
- Deciding whether a hospitalised medical (non-surgical) patient needs pharmacologic VTE prophylaxis.
Formula
Sum of weighted risk factors (2 points each for major factors such as cardiac/respiratory failure, active cancer, prior VTE, thrombophilia; 1 point each for minor factors such as age >60, obesity, immobilisation). Score >=3 defines high risk.
Pearls and pitfalls
- Compared favourably with the Padua Prediction Score for identifying truly low-risk patients who can safely forgo prophylaxis.